With proton therapy, “the man remains a man!” Thanks to the precision of proton beams, the risk of impotence (erectile dysfunction) is eliminated compared to conventional methods of treatment. The accuracy of the procedure is the most important factor to maintain male potency. One of the risk factors of surgery and conventional radiation therapy is intervention in the vicinity of nerves, the damage of which can cause erectile dysfunction. Protons also make it possible to reduce the unwanted radiation to the bulb of the penis (root of penis), which is one of the causes of the development of erectile dysfunction after radiotherapy. The term erectile dysfunction in men indicates persistent problems in achieving or maintaining an erection sufficient to complete intercourse. The term impotence is often used, which is not completely correct. Proton therapy helps you maintain your sexual life.
You don’t need to worry about wearing diapers after proton beam therapy! On the contrary, up to 30% of patients suffer from bladder weakness after surgery (complete removal of the prostate)! In conventional irradiation, this complication occurs in 5% of patients. In the case of proton therapy, the risk is minimized to a mere 1%. Urinary incontinence is involuntary leakage of a low amount of urine, which causes a social and/or hygiene problem for the patient or their caregivers. For active men, wearing a protective garment is a major problem. Proton therapy is the right solution if you want to avoid diapers.
Protons prevent the recurrence of cancer! Obviously, the most serious concern of the patient is whether the disease can return. The recurrence rate is 10% after surgical treatment and 8% after conventional irradiation. Based on decades of experience in proton centers in the USA and Japan, the recurrence rate after proton therapy is only about 1%. The scientific name for the return of cancer is relapse, a recurrence of the signs of the disease that were not detectable immediately after treatment. Proton therapy is a method to prevent recurrence of the disease.